Title:
ガンの予測および予後、ならびにガン治療を監視するための方法
Document Type and Number:
Japanese Patent JP2006518031
Kind Code:
A
Abstract:
The present invention also relates to biomarkers and the use of biomarkers for the prediction and prognosis of cancer as well as the use of biomarkers to monitor the efficacy of cancer treatment. Specifically, this invention relates to the use of adrenomedullin as a biomarker for Raf kinase inhibitors.
Inventors:
Evely, Dapa
Taylor, Ian
Taylor, Ian
Application Number:
JP2004540313A
Publication Date:
August 03, 2006
Filing Date:
September 30, 2003
Export Citation:
Assignee:
Bayer Pharmaceuticals Corporates Corporation
International Classes:
G01N33/53; A61B1/00; A61P35/00; A61P43/00; C12Q1/68; G01N33/15; G01N33/50; G01N33/574; A61K45/00; A61B
Attorney, Agent or Firm:
Heikichi Odashima